Establishment of flow cytometric in in vitro micronucleus assay
OU Hongmei，ZHOU Changhui，TU Honggang，HUANG Pengcheng，CHANG Yan*
China State Institute of Pharmaceutical Industry, Shanghai Institute of Pharmaceutical Industry, National Shanghai Center for New Drug Safety Evaluation & Research, Shanghai 201203, China
[1] Corvi R，Albertini S，Hartung T，et al. ECVAM retrospective validation of in vitro micronucleus test (MNT)[J]. Mutagenesis， 2008，23(4)：271-283.[2] OECD. Guidlines for Testing of Chemicals. In vitro mammalian cell micronucleus test (MNvit)[EB/OL]. [2013-05-20] http：// www. oecd.org/env/test guidelines. html.[3] ICH. International Conference on Harmonization. Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2 (R1)[EB/OL]. [2013-05-20]http： //www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2R1.html.[4] Bryce SM，Bemis JC，Mereness JA，et al. Interpreting In vitro micronucleus positive results：simple biomarker matrix discriminates clastogens，aneugens，and misleading positive agents[J]. Environ Mol Mutagen，2014. doi：10.1002/em.21868.[5] Tilmant K，Gerets HH，De Ron P，et al. The automated micronucleus assay for early assessment of genotoxicity in drug discovery[J]. Mutat Res，2013，751(1)：1-11.[6] Bull CF，Beetstra-Hill S，Benassi-Evans BJ，et al. Application and adaptation of the in vitro micronucleus assay for the assessment of nutritional requirements of cells for DNA damage prevention[J]. Mutagenesis，2011，26(1)：193-197.[7] Bryce SM，Avlasevich SL，Bemis JC，et al. Flow cytometric 96-well microplate-based in vitro micronucleus assay with human TK6 cells：protocol optimization and transferability assessment[J]. Environ Mol Mutagen，2013，54(3)：180-194.[8] Yao J，Gao Q，Mi Q，et al. In vitro micronucleus assay for the analysis of total particulate matter in cigarette smoke： Comparison of flow cytometry and laser scanning cytometry with microscopy[J]. Mutat Res，2013，755(2)：120-125.[9] Avlasevich SL，Bryce SM，Cairns SE，et al. In vitro micronucleus scoring by flow cytometry：differential staining of micronuclei versus apoptotic and necrotic chromatin enhances assay reliability[J]. Environ Mol Mutagen，2006，47(1)： 56-66.[10] Shi J，Bezabhie R，Szkudlinska A. Further evaluation of a flow cytometric in vitro micronucleus assay in CHO-K1 cells：a reliable platform that detects micronuclei and discriminates apoptotic bodies[J]. Mutagenesis，2010，25(1)：33-40.[11] Sobol Z，Homiski ML，Dickinson DA，et al. Development and validation of an in vitro micronucleus assay platform in TK6 cells [J]. Mutat Res，2012，746(1)：29-34.[12] Bryce SM，Shi J，Nicolette J，et al. High content flow cytometric micronucleus scoring method is applicable to attachment cell lines[J]. Environ Mol Mutagen，2010， 51(3)： 260-266.[13] Bryce SM，?Bemis JC，?Mereness JA，et al. Interpreting in vitro micronucleus positive results：simple biomarker matrix discriminates clastogens，aneugens，and misleading positive agents[J]. Environ Mol Mutagen，2014，55(7)：542-555.[14] Fowler P，?Smith R，?Smith K，et al. Reduction of mis-leading (“false”) positive results in mammalian cell genotoxicity assays. III：Sensitivity of human cell types to known genotoxic agents[J]. Mutat Res Genet Toxicol Environ Mutagen，2014，767：28-36.[15] Yuki K，Ikeda N，Nishiyama N，et al. The reconstructed skin micronucleus assay in EpiDerm?：Reduction of false-positive results-a mechanistic study with epigallocatech in gallate[J]. Mutat Res，2013，757(2)：148-157.[16] Jetten MJ，Kleinjans JC，Claessen SM，et al. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes[J]. Toxicol In Vitro，2013，27(7)：2031-2040.[17] Sun B，Ross SM，Trask OJ，et al. Assessing dose-dependent differences in DNA-damage，p53 response and genotoxicity for quercetin and curcumin[J]. Toxicol In Vitro，2013，27(6)： 1877-1887.
